RHI Magnesita India Ltd Q1 Revenue Rises 6% to ₹1,014 Crore

RHI Magnesita India Ltd reported Q1 FY27 revenue of ₹1,014 crore, up 6% year on year, while consolidated profit after tax rose 83% to ₹65 crore and operating EBITDA increased 42% to ₹147 crore. The result matters because margin expansion offset a relatively modest rise in sales amid pricing pressure and higher raw-material costs.

What did RHI Magnesita India Ltd report for Q1 FY27?

RHI Magnesita India Ltd reported revenue from operations of ₹1,014 crore for the quarter ended June 30, 2026, compared with ₹960 crore in the year-earlier quarter. The company described this as 6% year-on-year growth, while other reported data put the increase at 5.6%. Revenue was also reported to be about 9% higher sequentially.

The refractory maker reported shipment volumes of 122 KT during the quarter. Its total income was ₹1,023.25 crore, versus ₹961.42 crore in Q1 FY26, according to the quarterly-results data. The difference between total income and revenue from operations reflects that these are separate reported measures and should not be treated as the same line item.

Consolidated profit after tax rose to ₹65 crore from ₹35 crore a year earlier. The company also reported a standalone profit after tax of ₹78.19 crore for the quarter. Basic consolidated earnings per share were ₹3.13, while standalone basic earnings per share were ₹3.79.

How did RHI Magnesita India improve profitability?

RHI Magnesita India improved operating EBITDA to ₹147 crore in Q1 FY27, lifting its operating EBITDA margin to 14.5% from 10.8% in Q1 FY26. The margin was also above the 12.1% reported for the preceding quarter, while operating EBITDA was stated to be 30% higher quarter on quarter.

The faster growth in EBITDA and profit than in revenue indicates that the quarter's financial improvement was driven by better operating profitability. However, management did not treat the first-quarter margin as a run-rate for the full year. Chief Financial Officer Azim Syed reaffirmed guidance for a 13% EBITDA margin for FY27.

The company reported cash and cash equivalents of ₹452 crore and said its balance sheet remained net cash positive. Its net cash-to-EBITDA ratio was reported at 0.27x. These figures point to a balance sheet position that differs from a company with net borrowings, although the provided information does not give a full debt or cash-flow reconciliation.

What is known about RHI Magnesita India's Q2 and H1 FY27 results?

RHI Magnesita India said its board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, on November 13, 2026. The company scheduled an investor conference call for November 14, 2026 at 11:00 a.m. IST to discuss Q2 and H1 FY27 operating and financial performance.

The supplied filing summary says standalone and consolidated H1 revenue and profit increased year on year. It also says consolidated Q2 revenue was lower while profit increased, but it does not provide the underlying Q2 or H1 financial amounts, margins, volumes, or comparison bases. Those figures should therefore not be inferred from the Q1 release.

The filing summary further states that shareholders approved a dividend of ₹2.50 per share and that a chief financial officer transition will take effect on January 1, 2027. The announcement of approved results on November 13 and the conference call on November 14 explains the two dates appearing in the available disclosures.

What market conditions are affecting RHI Magnesita India?

RHI Magnesita India faces a competitive environment marked by pricing pressure and rising input costs, including a reported 6% to 8% increase in magnesite prices. Magnesite is a key raw material for refractory products, so movements in its price can affect costs and margins if they are not offset through procurement, pricing, product mix, or operating efficiencies.

Management moderated its FY27 volume-growth expectation to 7% to 8%, within its earlier 7% to 9% range. Non-Executive Chairman Parmod Sagar said 9% would be a stretch target, while management remained confident of delivering 7% to 8% growth depending on market conditions and order wins.

The industrial segment, including non-ferrous and glass applications, was weak in Q1 FY27, and the company reported no project-order bookings during the quarter. Management expects potential orders in coke ovens, glass, and silica applications in the second half of the financial year. This makes the order pipeline relevant to both volume growth and the mix of future sales.

How do the results affect investors and industry participants?

RHI Magnesita India's Q1 numbers showed that profit growth outpaced revenue growth, with EBITDA up 42% and profit after tax up 83% year on year. For investors, the key point is that the 14.5% first-quarter EBITDA margin exceeded the company's 13% full-year guidance, but management has not indicated that the quarterly level will be sustained.

For customers and industrial users, the company's commentary signals an operating environment where refractory suppliers are dealing with higher raw-material costs and competition. The reported weakness in non-ferrous and glass project activity also provides context for the lower volume-growth expectation, although no company-specific customer impact or pricing change was disclosed.

The next disclosed milestone is the Q2 and H1 FY27 discussion scheduled for November 14. Investors will be able to assess whether the profit improvement mentioned in the filing summary was supported by operating margins, volumes, order inflows, or other factors once detailed results and management commentary are available.

Conclusion

RHI Magnesita India's Q1 FY27 performance combined 6% revenue growth with substantially stronger profitability, as operating EBITDA reached ₹147 crore and consolidated profit after tax rose to ₹65 crore. The quarter also showed improved margins and a net cash-positive balance sheet, despite higher magnesite prices and competitive pricing conditions.

The immediate focus is the Q2 and H1 FY27 conference call on November 14, 2026. Management's 7% to 8% volume-growth outlook, 13% EBITDA-margin guidance, potential second-half project orders, and the CFO transition planned for January 1, 2027 are the disclosed matters to watch next.